KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $6.3 billion.

  • Elevance Health's Receivables - Other rose 483.71% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.3 billion, marking a year-over-year increase of 483.71%. This contributed to the annual value of $6.3 billion for FY2025, which is 483.71% up from last year.
  • Per Elevance Health's latest filing, its Receivables - Other stood at $6.3 billion for Q4 2025, which was up 483.71% from $7.7 billion recorded in Q3 2025.
  • In the past 5 years, Elevance Health's Receivables - Other registered a high of $7.7 billion during Q3 2025, and its lowest value of $1.5 billion during Q4 2021.
  • Moreover, its 5-year median value for Receivables - Other was $5.2 billion (2023), whereas its average is $4.9 billion.
  • As far as peak fluctuations go, Elevance Health's Receivables - Other crashed by 4699.65% in 2021, and later surged by 18653.33% in 2022.
  • Over the past 5 years, Elevance Health's Receivables - Other (Quarter) stood at $1.5 billion in 2021, then soared by 186.53% to $4.3 billion in 2022, then increased by 25.76% to $5.4 billion in 2023, then increased by 11.3% to $6.0 billion in 2024, then grew by 4.84% to $6.3 billion in 2025.
  • Its last three reported values are $6.3 billion in Q4 2025, $7.7 billion for Q3 2025, and $7.2 billion during Q2 2025.